T 淋巴细胞及其在利维体痴呆症中的潜在作用
Jay Amin1,2, Claire Gee1,2, Kiran Stowell1
1Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, UK.
Cells
|September 28, 2023
概括
T淋巴细胞在常见的神经退行性疾病 - - 勒维体痴呆症 (DLB) 中起着至关重要的作用. 了解大脑和血液中的T淋巴细胞变化可能会导致DLB的新疗法.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 神经病理学神经病理学
背景情况:
- 患有莱维体的痴呆症 (DLB) 是第二常见的神经退行性痴呆症,预后比阿尔茨海默病 (AD) 更差.
- DLB和AD的神经病理和临床症状重叠,需要更深入地了解DLB的病因和病原体.
- 外周炎症对痴呆症的影响越来越多地被研究,在AD和帕金森病中观察到T淋巴细胞透.
研究的目的:
- 审查目前关于在患有勒维体痴呆症 (DLB) 的T淋巴细胞概况的文献.
- 在DLB患者中检查T淋巴细胞在死后脑组织,脑脊液和血液中的参与.
- 提出DLB病原体中外围和中心T淋巴细胞变化之间的联系.
主要方法:
- 对DLB中T淋巴细胞的现有研究进行系统审查.
- 对死后脑组织,脑脊液和血液样本数据的分析.
- 整合发现,提出T淋巴细胞参与的统一模型.
主要成果:
- 新兴文献表明,在DLB.中,先天性和适应性免疫细胞,包括T淋巴细胞,起着作用.
- 研究重点关注大脑组织,中枢神经液和血液中的T淋巴细胞概况.
- 关于中央和外围T淋巴细胞变化之间的关系的综合观点.
结论:
- 了解DLB中的T淋巴细胞概况对于推进病因学和病原学知识至关重要.
- 研究DLB中的T淋巴细胞可能会揭示潜在的治疗点.
- 这项研究可以指导DLB的疾病修饰治疗的开发.
更多相关视频
相关概念视频
T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
Alzheimer's Disease: Overview
513
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
513
Dementia
131
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
131
Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
Parkinson's Disease: Overview
590
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
590
B Cell Activation and Differentiation
1.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.8K


